Immune responses to alpha1,3 galactosyltransferase knockout pigs

Gisella Puga Yung1, Mårten K J Schneider, Jörg D Seebach

  • 1Service of Clinical Immunology and Allergology, Department of Internal Medicine, University Hospital and Medical Faculty, Geneva, Switzerland.

Summary

Genetically modified pigs lacking alpha1,3-galactosyltransferase (GalT-KO) show negligible Gal expression, reducing but not eliminating immune responses. New research identifies non-Gal antigens and cellular responses crucial for xenograft survival.

Related Concept Videos